Genetic testing prior to starting standard chemotherapy for gastrointestinal cancer could substantially reduce toxicities for ...

In the Japanese multicenter registry, detectable leaks at Watchman device implantation were linked with a significant ...

Neoadjuvant immunotherapy combined with chemotherapy shows promising results in treating limited-stage small cell lung cancer ...

A peanut oral immunotherapy protocol using parent-measured dosing may safely desensitize children aged 1-4 years with peanut ...

Adjuvant chemoradiation combined with camrelizumab was well tolerated and yielded significantly improved long-term survival,” the researchers wrote.

FDA confirmed at a July 2025 Type B meeting and in the subsequent meeting minutes that eGFR slope is an acceptable surrogate endpoint for ...

James D. Chalmers, MBChB, PhD, explains that the ASPEN trial findings show that brensocatib reduces exacerbations, slows lung function decline at higher doses, and offers clinicians a long-awaited ...

The botulinum toxin product CKDB-501A is non-inferior to onabotulinumtoxin A for the treatment of moderate to severe glabellar lines.

Phase 2 study showed a doubling of the survival rate of metastatic pancreatic cancer patients at Year 1, an unprecedented ...

Major pharmaceutical companies Glenmark, Alembic Pharmaceuticals, and Sun Pharma recall products in the US due to ...

The primary path to full approval from conditional approval is the pivotal efficacy study—a tightly controlled, high-quality ...

In the APOLLO trial, first-line treatment with anlotinib plus penpulimab improved progression-free survival and overall survival when compared to sorafenib.